GTHX

G1 Therapeutics, Inc. Common Stock

Delisted

GTHX was delisted on the 17th of September, 2024.

94 hedge funds and large institutions have $741M invested in G1 Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 37 increasing their positions, 11 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$45.3M
2 +$41.3M
3 +$27.4M
4
BlackRock
BlackRock
New York
+$19.8M
5
Capital World Investors
Capital World Investors
California
+$17.6M

Top Sellers

1 -$8.44M
2 -$6.58M
3 -$4.44M
4
EA
Emerald Advisers
Pennsylvania
-$705K
5
Goldman Sachs
Goldman Sachs
New York
-$299K
Name Holding Trade Value Shares
Change
Change in
Stake
76
$105K
77
$104K
78
$88K
79
$85K
80
$83K
81
$74K
82
$70K
83
$68K
84
$56K
85
$44K
86
$42K
87
$40K
88
$39K
89
$32K
90
$32K
91
$8K
92
$7K
93
$7K
94
$6K
95
96
97
98